Decreased alloreactivity after vaccination against hepatitis B

The beneficial effect of blood transfusions on renal allografts disappeared at about the same time when hepatitis B vaccination was introduced in dialysis patients. To determine possible immunosuppressive effects of hepatitis B vaccination, we studied alloreactivity during the course of immunization...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ruder, Hans (VerfasserIn) , Kerling, Frank (VerfasserIn) , Daniel, Volker (VerfasserIn) , Korn, Klaus (VerfasserIn) , Waßmuth, Ralf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: May 15, 1995
In: Transplantation
Year: 1995, Jahrgang: 59, Heft: 9, Pages: 1339-1342
ISSN:1534-6080
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/transplantjournal/abstract/1995/05150/decreased_alloreactivity_after_vaccination_against.20.aspx
Volltext
Verfasserangaben:Hans Ruder, Frank Kerling, Volker Daniel, Klaus Korn, Ralf Wassmuth
Beschreibung
Zusammenfassung:The beneficial effect of blood transfusions on renal allografts disappeared at about the same time when hepatitis B vaccination was introduced in dialysis patients. To determine possible immunosuppressive effects of hepatitis B vaccination, we studied alloreactivity during the course of immunization. Fourteen healthy subjects without serological evidence of hepatitis B were routinely immunized against hepatitis B surface antigen. Plasma and mononuclear cells were isolated and frozen before immunization and after vaccination, respectively. Mean alloreactivity measured by [3H]thymidine uptake decreased from 64,772 cpm before immunization to 40,213 cpm after the third immunization. In crossover experiments, cellular modulation and plasma-dependent modulation of alloreactivity were observed. The immunosuppressive effect of plasma taken 4 weeks after the third vaccination correlated (r=0.9) highly significantly (P<0.005) with the anti-hepatitis B surface antigen antibody titer. Taken together, our data strongly suggest that hepatitis B vaccination is capable of reducing allogenic reactivity.
Beschreibung:Gesehen am 22.08.2024
Beschreibung:Online Resource
ISSN:1534-6080